Multiple site testing evaluation, Lancing device. ascensia, Reeze – Bayer HealthCare Ascensia BREEZE and Ascensia AUTODISCTM Unique 10-Test Disc User Manual

Page 43: Icrolet, Aculance

Advertising
background image

MULTIPLE SITE TESTING EVALUATION:

Forty-one persons with diabetes, in steady state for glucose,
performed self-capillary blood glucose assays using the
Ascensia

®

B

REEZE

™ System and one test strip lot (Lot A). A

fingerstick was performed with the M

ICROLET

®

Adjustable

Lancing Device. Samples from the palm, forearm, thigh and
abdomen were obtained using the M

ICROLET

®

V

ACULANCE

Lancing Device. Ascensia

®

B

REEZE

™ results from the multiple

sites were compared to those obtained from the finger. The
blood glucose range for the fingerstick measurements was
3.3 to 13.6 mmol/L, with an average of 7.5 mmol/L. The
hematocrit range was 38 to 53%, with an average of 45%.

37

0

5

1 0

1 5

2 0

1 0

1 5

5

0

2 0

Ascensia

®

B

REEZE

Finger Stick Result (mmol/L)

y=x

0

5

1 0

1 5

2 0

0

5

1 0

1 5

2 0

y=x

Ascensia

®

B

REEZE

Palm Result (mmol/L)

Ascensia

®

B

REEZE

™ Forearm Result (mmol/L)

Ascensia

®

B

REEZE

Finger Stick Result (mmol/L)

A. Results from Palm (n = 36)

B. Results from Forearm (n = 30)

Advertising